A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon

• Ena Wang ,

  Contributed equally to this work with: Ena Wang, Yingdong Zhao

  Affiliation Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Yingdong Zhao ,

  Contributed equally to this work with: Ena Wang, Yingdong Zhao

  Affiliation Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Alessandro Monaco,

  Affiliation Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Lorenzo Uccellini,

  Affiliation Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• John M. Kirkwood,

  Affiliation University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Maria Spyropoulou-Vlachou,

  Affiliation Department of Immunology, National Tissue Typing Center, General Hospital of Athens, Athens, Greece

  ⨯
• Monica C. Panelli,

  Affiliation University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Francesco M. Marincola,

  Affiliation Department of Transfusion Medicine, Clinical Center and Trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Helen Gogas

  * E-mail: hgogas@hol.gr

  Affiliation First Department of Medicine, University of Athens, Medical School, Athens, Greece

  ⨯